- Report
- February 2024
- 113 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- March 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- October 2023
- 146 Pages
Global
From €3353EUR$3,528USD£2,817GBP
€3945EUR$4,150USD£3,314GBP
- Report
- January 2023
- 221 Pages
Global
From €3422EUR$3,600USD£2,875GBP
- Report
- January 2025
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- January 2025
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Book
- February 2018
- 864 Pages
The Cell Harvesting market within the biotechnology industry is a rapidly growing sector that focuses on the collection and processing of cells for use in research and medical applications. Cell harvesting is a critical step in the production of biopharmaceuticals, such as vaccines, antibodies, and other therapeutic proteins. It involves the collection of cells from a variety of sources, including cell cultures, tissue samples, and blood. The harvested cells are then processed and purified for use in research and medical applications.
Cell harvesting technologies have advanced significantly in recent years, allowing for more efficient and cost-effective collection and processing of cells. This has enabled the development of new biopharmaceuticals and other therapeutic products.
Companies in the Cell Harvesting market include Thermo Fisher Scientific, Merck KGaA, Sartorius AG, Danaher Corporation, and Becton Dickinson. Show Less Read more